Reporting owner · CIK 0001658369

Shenouda Maged

Visual SEC Form 4 history across 1 companies, 2 transactions and 1 filings.

CFOChief Financial OfficerRELMADA THERAPEUTICS, INC.
Open-market mix
Latest filingSep 11, 2026, 11:30 AM
Filings1Form 4 records
Buying$844K2 purchases
Selling$00 sales
Net value$844KBuys minus sells
Companies11 securities
Most recentSep 10, 2026buy

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-52Sep 26

Net value flow

Buys minus sells

Sep 26
$844K

Transaction texture

Ownership and ticket size

Average P/S size$422K
Median P/S size$422K
Direct2
Indirect0
Sep 10, 2026buy

Filing-only signals

Deterministic matches in this insider's history

No filing-only signal badges matched this history.

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at RELMADA THERAPEUTICS, INC. on Sep 10, 2026 valued at $339,150.

Review SEC filing
Latest buy

buy at RELMADA THERAPEUTICS, INC. on Sep 10, 2026 valued at $339,150.

Review SEC filing
Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

RLMDRELMADA THERAPEUTICS, INC.2 transactions · latest Sep 11, 2026, 11:30 AM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
RLMDShenouda Maged
CFO
buy79.8k$33.9MP
CFO Buy Cluster Buy Direct Ownership+1
—09/1109/10
RLMDShenouda Maged
CFO
buy120k$50.4MP
CFO Buy Cluster Buy Direct Ownership
—09/1109/09

Shenouda Maged Insider Activity FAQ

SEC Form 4 context

Who is Shenouda Maged?

Shenouda Maged is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001658369.

Which companies has Shenouda Maged reported transactions for?

RELMADA THERAPEUTICS, INC.

When was Shenouda Maged's latest insider buy?

buy at RELMADA THERAPEUTICS, INC. on Sep 10, 2026 valued at $339,150.

When was Shenouda Maged's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.